UK launch for Bial’s Parkinson’s drug
Patients with Parkinson’s disease in the UK can now potentially access a new option to treat motor fluctuations with the launch of Bial’s Ongentys across the country.
Read More
Tag: opicapone
EU clears Bial’s new Parkinson’s drug
The European Commission has approved Bial’s Ongentys for Parkinson’s disease patients with motor fluctuations.
Read More
- MHRA to open new Northern Ireland hub to strengthen UK‑wide life sciences collaboration
- Novo Nordisk data shows oral semaglutide delivers significant weight loss in phase 3 trial
- Enterprise reports positive phase 2 data for inhaled ENaC blocker in cystic fibrosis
- SMC backs first-line metastatic bladder cancer combination after trial results
- Poolbeg secures Canadian patent for POLB 001 in cancer immunotherapy‑induced CRS
